Completed NA INTERVENTIONAL 1-arm NCT04402840

Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS)

Sponsor: West Virginia University

Conditions Acute Respiratory Distress Syndrome COVID-19

Updated 7 times since 2020 Last updated: Apr 22, 2025 Started: Apr 24, 2020 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Respiratory Distress Syndrome and COVID-19, this trial is completed. The trial is conducted by West Virginia University and has accumulated 7 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

May 2025 — Present [monthly]

Completed NA
Sep 2024 — May 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Sep 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Sep 2022 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Dec 2020 — Jan 2021 [monthly]

Recruiting NA
Jun 2020 — Dec 2020 [monthly]

Recruiting NA

First recorded

Apr 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

West Virginia University

Data source: West Virginia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Morgantown, United States